FDA Designates Opioid Oxygenation Monitor as Class II Medical Device

The FDA has categorized a new monitor designed to detect oxygen impairment from opioid overdose as a Class II medical device, requiring special controls. This classification acknowledges the device's role in enhancing patient safety by identifying dangerous drops in oxygen saturation. The technology utilizes sensors and algorithms to provide early detection of overdose effects.